Download PDF
Thromb Haemost 2016; 115(03): 682-684
DOI: 10.1160/th15-08-0683
Letters to the Editor
Schattauer GmbH

The association of F11 genetic variants with the risk of incident venous thrombosis among women, by statin use

Laura B. Harrington
1   Department of Epidemiology, University of Washington, Seattle, Washington, USA
2   Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA
,
Kerri L. Wiggins
3   Department of Medicine, University of Washington, Seattle, Washington, USA
,
Colleen M. Sitlani
3   Department of Medicine, University of Washington, Seattle, Washington, USA
,
Marc Blondon
1   Department of Epidemiology, University of Washington, Seattle, Washington, USA
4   Division of Angiology and Haemostasis, Geneva University Hospitals, Geneva, Switzerland
,
Astrid van Hylckama Vlieg
5   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
,
Frits R. Rosendaal
5   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
6   Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
,
Susan R. Heckbert
1   Department of Epidemiology, University of Washington, Seattle, Washington, USA
7   Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA
,
Bruce M. Psaty
1   Department of Epidemiology, University of Washington, Seattle, Washington, USA
3   Department of Medicine, University of Washington, Seattle, Washington, USA
7   Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA
8   Department of Health Services, University of Washington, Seattle, Washington, USA
,
Nicholas L. Smith
1   Department of Epidemiology, University of Washington, Seattle, Washington, USA
7   Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA
9   Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA
› Author Affiliations Financial support: This study was supported by the National Heart, Lung, and Blood Institute (NHLBI) Cardiovascular Disease Training Grant (HL007902, David S. Siscovick) as well as grants HL043201 (B. M. Psaty), HL060739 (B. M. Psaty), HL068986 (S. R. Heckbert), HL073410 (N. L. Smith), HL074745 (B. M. Psaty), HL085251 (B. M. Psaty), HL095080, and HL121414 (N. L. Smith) from the NHLBI.
Further Information

Publication History

Received: 26 August 2015

Accepted after minor revision: 29 October 2015

Publication Date:
20 March 2018 (online)

    Permissions and Reprints

Supplementary Material to this article is available online at www.thrombosis-online.com.

Supplementary Material

 

  • References

  • 1 Smith NL, Hindorff LA, Heckbert SR. et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. J Am Med Assoc 2007; 297: 489-498.
    CrossrefPubMedGoogle Scholar
  • 2 Bezemer ID, Bare LA, Doggen CJ. et al. Gene variants associated with deep vein thrombosis. J Am Med Assoc 2008; 299: 1306-1314.
    CrossrefPubMedGoogle Scholar
  • 3 Li Y, Bezemer ID, Rowland CM. et al. Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost 2009; 7: 1802-1808.
    CrossrefPubMedGoogle Scholar
  • 4 Ray JG, Mamdani M, Tsuyuki RT. et al. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161: 1405-1410.
    CrossrefPubMedGoogle Scholar
  • 5 Doggen CJ, Lemaitre RN, Smith NL. et al. HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost 2004; 2: 700-701.
    CrossrefPubMedGoogle Scholar
  • 6 Glynn RJ, Danielson E, Fonseca FA. et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009; 360: 1851-1861.
    CrossrefPubMedGoogle Scholar
  • 7 Bare LA, Arellano AR, Tong CH. et al. Genetic variants of F11, statin use and venous thrombosis. J Thromb Haemost 2011; 9: 1249-1251.
    CrossrefPubMedGoogle Scholar
  • 8 Smith NL, Heckbert SR, Lemaitre RN. et al. Esteri-fied estrogens and conjugated equine estrogens and the risk of venous thrombosis. J Am Med Assoc 2004; 292: 1581-1587.
    CrossrefPubMedGoogle Scholar
  • 9 Abecasis GR, Auton A, Brooks LD. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
    CrossrefPubMedGoogle Scholar
  • 10 Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 2012; 41: 514-520.
    CrossrefPubMedGoogle Scholar
  • 11 VanderWeele T, MJ K. A tutorial on interaction. Epidemiologic Methods 2014; 3: 33-72.
    PubMedGoogle Scholar